Fall 2009
Improving Healthcare Quality Through Comparative Effectiveness Research and Value-Based Insurance Design
September 02, 2010
Article
The American Journal of Pharmacy Benefits
The President of the National Pharmaceutical Council discusses how comparative effectiveness research and value-based insurance design can reduce costs and improve healthcare quality.
Generational Impact on Prescription Drug Trend: Part 2
September 01, 2010
Article
The American Journal of Pharmacy Benefits
This retrospective study of 558.9 million prescription claims explores how member age demographics affect prescription drug trends and provides top therapeutic classes by generation.
A Neccessary Balancing Act: Accessibility, Cost, and Need for New and Better Cures
September 01, 2010
Article
The American Journal of Pharmacy Benefits
Focusing first on patient needs is the key to finding a meaningful and effective solution to the complex issues regarding regulation of biosimilars.
Impact of Antidepressant Therapy on Statin Adherence and Cholesterol Control
September 01, 2010
Article
The American Journal of Pharmacy Benefits
Among patients with poor statin adherence, adequate antidepressant treatment significantly improved adherence and persistence compared with inadequate or no antidepressant treatment.
Comparison of Pharmacists and Primary Care Providers as Immunizers
September 01, 2010
Article
The American Journal of Pharmacy Benefits
Pharmacist-administered vaccination services were found to be more efficient, productive, and cost-effective than primary care visits or mass vaccination clinics.
A Look Ahead: Future Direction and Collaboration
September 02, 2009
Article
The American Journal of Pharmacy Benefits
The Society seeks input from both individuals and organizations as it creates a new environment of data-driven P&T best practices.
Change We Can Believe In: Requiring Better Evidence for Formulary Coverage
September 02, 2009
Article
The American Journal of Pharmacy Benefits
P&T committees should implement more rigorous formulary restrictions that stimulate manufacturers to meet a higher standard when bringing new therapies to market.
Formulary Coverage for Antihypertensive Drugs Used in Children
September 01, 2009
Article
The American Journal of Pharmacy Benefits
Differences in formulary coverage of antihypertensive medications for children between private and public insurance plans may impact physician prescribing practices and patient outcomes.
Impact of New Antihypertensives on Healthcare Utilization by Hypertensive Patients
September 01, 2009
Article
The American Journal of Pharmacy Benefits
The authors advocate pharmacoeconomic evaluation of new antihypertensive drugs before acceptance by formulary decision makers.